UNITED STATES AMNIOTIC MEMBRANE MARKET FORECAST 2023-2030

UNITED STATES AMNIOTIC MEMBRANE MARKET FORECAST 2023-2030
United States Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilized Amniotic Membrane) Market by Application (Surgical Wounds, Ophthalmology, Other Applications) Market by End-user (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories)
The United States amniotic membrane market is expected to register a CAGR of 7.04% during the forecast period, 2023-2030, reaching a revenue share of $900.91 million by 2030.
The market growth is accredited to the rising investments in amniotic membranes and the increasing implementation of amniotic membranes in medical science. At the same time, the market growth is hampered by the costly surgeries and treatments, with fewer insurance facilities that cover costs.
To know more about this report, request a free sample copy
Amniotic membrane (AM) is the innermost fetal layer that lines the amniotic cavity and protects the fetus during pregnancy. The chorionic membrane, i.e., the outer layer, separates the fetus from maternal tissues.
Also, there has been increased research on the physiological functions of fetal layers. Such developments project that the amniotic membrane offers physical support for the fetus. In addition, AM’s anti-scarring, anti-inflammatory, avascular, low immunogenic, wound healing, and translucent properties enable its varied regenerative medicine applications.
One of AM’s earliest applications is in skin burn treatment. This played a substantial role in advancing the amniotic membrane use in surgery in areas like conjunctival and corneal surfaces, skin transplantation, and wounds and open ulcers treatment.
Furthermore, glycerol preservation, cryo-preservation, lyophilization, air-drying, and irradiation techniques extend AM’s shelf life. Besides, these are set to increase the use of AM in ophthalmology for treating limbal, corneal and conjunctival lesions, defects, scars, and burns and reconstruction surgeries of the genitourinary tract, skin, and other surfaces.
In the United States, healthcare service providers are raising awareness about AM for minimizing the suffering from third-degree chronic burn wounds. Additionally, stem cell-based amniotic membranes are estimated to witness high growth during the forecast period.
The segmentation analysis of the United States amniotic membrane market includes end-user, application, and product. The product segment is further sub-segmented into lyophilization amniotic membrane and cryopreserved amniotic membrane. Cryopreserved amniotic membrane has high adoption rates worldwide due to its high efficiency. It is conventionally stored in a cell culture medium with 50% glycerol at -80°C.
Also, AM is well-preserved in cryopreserved AM with biological and histological properties. These membranes are mostly used in visual surgeries that aid in enhanced recovery and reduced eye inflammation.
Further, lyophilization is a preservative method that uses the drying by freezing process to sustain AM at room temperature for longer durations. It is mounted on blue paper. It is also known as a sterilized, freeze-dried amniotic membrane.
As per clinical research, LAM (lyophilized amniotic membrane) is also a good method to preserve human AM for use in ocular surface reconstruction. Further, this method enhances AM use and decreases preservation costs, thereby enabling its transport and storage. Moreover, it maintains the advantageous properties of ocular bandages and offers enhanced biocompatibility.
Some of the eminent firms in the United States amniotic membrane market are Amino Technology LLC, Stryker Corporation, BioTissue Inc, etc.
Stryker Corporation is a leading player in the medical technology industry. It operates through various segments for services and products in the medical sectors like neurotechnology & spine, medical & surgical, and orthopedics. Also, it is a top provider of surgical technology in the global market. Additionally, it is among the top five leading players operating in the neurovascular devices market.
AlloWraps DS is a dual-layer amniotic membrane featuring 2 layers of the amniotic issue and outward-facing epithelial layers. Its processing facilitates Omni-directional implantation.
Report Synopsis
Report Scope | Details |
Market Forecast Years | 2023-2030 |
Base Year | 2022 |
Market Historical Years | 2018-2021 |
Forecast Units | Revenue ($ Million) |
Segments Analyzed | Product, Application, End-User |
Country Analyzed | The United States |
Companies Analyzed |
Integra LifeSciences, MiMedx Group Inc, Organogenesis Inc, Smith & Nephew Plc, Stryker Corporation |
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- COUNTRY SNAPSHOT
- COUNTRY ANALYSIS
- SCOPE OF STUDY
- CRISIS SCENARIO ANALYSIS
- IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
- MAJOR MARKET FINDINGS
- AMNIOTIC MEMBRANE IS MAJORLY USED FOR OCULAR APPLICATIONS
- STRATEGIC DEVELOPMENTS BY KEY PLAYERS
- MARKET DYNAMICS
- KEY DRIVERS
- INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
- GROWING AWARENESS REGARDING NUMEROUS APPLICATIONS OF AMNIOTIC MEMBRANE
- RISING DEMAND FOR WOUND CARE TREATMENT
- KEY RESTRAINTS
- DIFFICULTIES ASSOCIATED WITH AMNIOTIC MEMBRANE USE
- LACK OF SKILLED PROFESSIONALS
- KEY DRIVERS
- KEY ANALYTICS
- KEY MARKET TRENDS
- PESTLE ANALYSIS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRANTS
- INDUSTRY RIVALRY
- GROWTH PROSPECT MAPPING
- GROWTH PROSPECT MAPPING FOR UNITED STATES
- MARKET MATURITY ANALYSIS
- MARKET CONCENTRATION ANALYSIS
- MARKET BY PRODUCT
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- LYOPHILIZED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET BY APPLICATION
- SURGICAL WOUNDS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OPHTHALMOLOGY
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OTHER APPLICATIONS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SURGICAL WOUNDS
- MARKET BY END-USER
- HOSPITALS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- AMBULATORY SURGICAL CENTERS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SPECIALIZED CLINICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- RESEARCH CENTERS & LABORATORIES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- HOSPITALS
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- COMPANY PROFILES
- BIOTISSUE INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- CELULARITY
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- INTEGRA LIFESCIENCES
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- LABTICIAN OPHTHALMICS INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- MIMEDX GROUP INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- ORGANOGENESIS INC
- COMPANY OVERVIEW
- FINANCIAL ANALYSIS
- PRODUCT LIST
- STRENGTHS & CHALLENGES
- STRYKER CORPORATION
- COMPANY OVERVIEW
- PRODUCT LIST
- BIOTISSUE INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: UNITED STATES MARKET SNAPSHOT – AMNIOTIC MEMBRANE
TABLE 2: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 3: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY PRODUCT, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 4: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 5: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY APPLICATION, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 6: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 7: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY END-USER, FORECAST YEARS, 2023-2030 (IN $ MILLION)
TABLE 8: UNITED STATES REGULATORY FRAMEWORK
TABLE 9: KEY PLAYERS OPERATING IN UNITED STATES AMNIOTIC MEMBRANE MARKET
TABLE 10: LIST OF ACQUISITIONS
TABLE 11: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 12: LIST OF PARTNERSHIPS & AGREEMENTS
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: UNITED STATES AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2022
FIGURE 7: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2023-2030 (IN $ MILLION)
FIGURE 8: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZED AMNIOTIC MEMBRANE, 2023-2030 (IN $ MILLION)
FIGURE 9: UNITED STATES AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2022
FIGURE 10: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY PRODUCT, 2023-2030 (IN $ MILLION)
FIGURE 11: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2023-2030 (IN $ MILLION)
FIGURE 12: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2023-2030 (IN $ MILLION)
FIGURE 13: UNITED STATES AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 14: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY HOSPITALS, 2023-2030 (IN $ MILLION)
FIGURE 15: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTRES, 2023-2030 (IN $ MILLION)
FIGURE 16: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2023-2030 (IN $ MILLION)
FIGURE 17: UNITED STATES AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTERS & LABORATORIES, 2023-2030 (IN $ MILLION)
FIGURE 18: CELULARITY- COMPANY NET PROFIT, IN 2018-2021 (IN $ MILLION)
FIGURE 19: CELULARITY- COMPANY REVENUE, IN 2018-2021 (IN $ MILLION)
FIGURE 20: INTEGRA LIFESCIENCES – COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 21: INTEGRA LIFESCIENCES- COMPANY REVENUE, IN 2017-2021 (IN $ BILLION)
FIGURE 22: MIMEDX GROUP INC – COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 23: MIMEDX GROUP INC- COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)
FIGURE 24: ORGANOGENESIS INC – COMPANY NET PROFIT, IN 2017-2021 (IN $ MILLION)
FIGURE 25: ORGANOGENESIS INC – COMPANY REVENUE, IN 2017-2021 (IN $ MILLION)
- MARKET BY PRODUCT
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- LYOPHILIZED AMNIOTIC MEMBRANE
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- CRYOPRESERVED AMNIOTIC MEMBRANE
- MARKET BY APPLICATION
- SURGICAL WOUNDS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OPHTHALMOLOGY
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- OTHER APPLICATIONS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SURGICAL WOUNDS
- MARKET BY END-USER
- HOSPITALS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- AMBULATORY SURGICAL CENTERS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- SPECIALIZED CLINICS
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- RESEARCH CENTERS & LABORATORIES
- MARKET FORECAST FIGURE
- SEGMENT ANALYSIS
- HOSPITALS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.